Literature DB >> 21607138

Molecular mechanisms of cholangiocarcinoma.

Giammarco Fava1.   

Abstract

Cholangiocarcinoma (CC), the malignant tumor of the epithelial cells lining the biliary ducts, has undergone a worldwide increase in incidence and mortality. The malignant transformation of the biliary cells originates from a multistep process evolving through chronic inflammation of the biliary tract to CC. In the last few years several advances have been towards understanding and clarifying the molecular mechanisms implicated in the cholangiocarcinogenesis process. However, many pathophysiologic aspects governing the growth of CC are still undefined. The poor prognosis of this tumor underlines the urgent need to codify the underlying molecular mechanisms involved in the growth and progression of CC in order to design effective preventive measures and valid treatment regimens. This review reports on progresses made in the last few years in clarifying the molecular pathways involved in the process of cholangiocarcinogenesis.

Entities:  

Keywords:  Apoptosis.; Cholangiocarcinogenesis; Cholangiocarcinoma; Genetic; Invasion; Molecular mechanism

Year:  2010        PMID: 21607138      PMCID: PMC3097940          DOI: 10.4291/wjgp.v1.i1.12

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  108 in total

Review 1.  Cholangiocarcinoma.

Authors:  Konstantinos N Lazaridis; Gregory J Gores
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

2.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

Review 3.  Cholangiocarcinoma.

Authors:  Shahid A Khan; Howard C Thomas; Brian R Davidson; Simon D Taylor-Robinson
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

Review 4.  COX-2: a molecular target for colorectal cancer prevention.

Authors:  Joanne R Brown; Raymond N DuBois
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

5.  Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis.

Authors:  Norihisa Ishimura; Steven F Bronk; Gregory J Gores
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 6.  HGF/SF-Met signaling in tumor progression.

Authors:  Chong Feng Gao; George F Vande Woude
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

7.  Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.

Authors:  Shogo Kobayashi; Nathan W Werneburg; Steven F Bronk; Scott H Kaufmann; Gregory J Gores
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

Review 8.  Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.

Authors:  Alphonse E Sirica
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

9.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 10.  The molecular pathogenesis of cholangiocarcinoma.

Authors:  Eric P Berthiaume; Jack Wands
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

View more
  11 in total

1.  Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance.

Authors:  Xiao-Ping Tan; Qing Zhang; Wei-Guo Dong; Xia-Wen Lei; Zi-Rong Yang
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

2.  Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.

Authors:  P Chusorn; N Namwat; W Loilome; A Techasen; C Pairojkul; N Khuntikeo; A Dechakhamphu; C Talabnin; W Chan-On; C K Ong; B T Teh; P Yongvanit
Journal:  Tumour Biol       Date:  2013-02-17

3.  Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma.

Authors:  Tzu-Hung Hsiao; Hung-I Harry Chen; Jo-Yang Lu; Pei-Ying Lin; Charles Keller; Sarah Comerford; Gail E Tomlinson; Yidong Chen
Journal:  Transl Cancer Res       Date:  2013-02-01       Impact factor: 1.241

4.  Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?

Authors:  Mia Kumar; Xuelian Zhao; Xin Wei Wang
Journal:  Cell Biosci       Date:  2011-01-24       Impact factor: 7.133

5.  Diagnostic and prognostic serum marker of cholangiocarcinoma (Review).

Authors:  Xiaojun Zeng; Hualin Tao
Journal:  Oncol Lett       Date:  2014-11-10       Impact factor: 2.967

Review 6.  The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.

Authors:  Abigail Zabron; Robert J Edwards; Shahid A Khan
Journal:  Dis Model Mech       Date:  2013-03       Impact factor: 5.758

Review 7.  Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases.

Authors:  Ting Liu; Yu Zhou; Kwang Suk Ko; Heping Yang
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

8.  Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.

Authors:  Kern Rei Chng; Sock Hoai Chan; Amanda Hui Qi Ng; Chenhao Li; Apinya Jusakul; Denis Bertrand; Andreas Wilm; Su Pin Choo; Damien Meng Yew Tan; Kiat Hon Lim; Roy Soetinko; Choon Kiat Ong; Dan G Duda; Simona Dima; Irinel Popescu; Chaisiri Wongkham; Zhu Feng; Khay Guan Yeoh; Bin Tean Teh; Puangrat Yongvanit; Sopit Wongkham; Vajaraphongsa Bhudhisawasdi; Narong Khuntikeo; Patrick Tan; Chawalit Pairojkul; Joanne Ngeow; Niranjan Nagarajan
Journal:  EBioMedicine       Date:  2016-05-06       Impact factor: 8.143

9.  Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo.

Authors:  Rittibet Yapasert; Nirush Lertprasertsuk; Subhawat Subhawa; Juthathip Poofery; Bungorn Sripanidkulchai; Ratana Banjerdpongchai
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

10.  Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis.

Authors:  Longfei Dai; Wendi Hu; Zhenjie Yang; Diyu Chen; Bin He; Yunhao Chen; Lin Zhou; Haiyang Xie; Jian Wu; Shusen Zheng
Journal:  Lab Invest       Date:  2019-01-21       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.